You just read:

New NHANES Analysis Shows No Improvement in Last Decade to Get More Diabetes Patients to HbA1c Goal; Separate Study Suggests Reduced Efficacy in Real-World Plays Large Role Due to Adherence Falling Far Short of Clinical Trials

News provided by

Intarcia Therapeutics, Inc.

Jun 12, 2016, 13:01 ET